Human Oncology & Pathogenesis Program
Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.
Molecular Biology Program
Molecular biologist C. David Allis investigates the histone code and its impact on gene regulation and chromosome dynamics.
Computational Biology Program
Computational biologist Grégoire Altan-Bonnet focuses on probing and testing the integration of cellular activation that makes up the immune response.
Memorial Hospital Research Laboratories
Physician-scientist Cristina Antonescu studies the molecular pathogenesis of soft tissue sarcomas and gastrointestinal stromal tumors.
Human Oncology & Pathogenesis Program
Physician-scientist Scott Armstrong focuses on defining genetic and epigenetic programs that control the extensive self-renewal properties associated with leukemia and other cancers.
Developmental Biology Program
Developmental biologist Zhirong Bao investigates how the genome dictates development using C. elegans as a model.
Physician-in-Chief, Memorial Hospital
Human Oncology & Pathogenesis Program
Memorial Sloan-Kettering Physician-in-Chief José Baselga studies mechanisms of resistance to targeted therapies and identification of novel therapeutic combinations in solid cancers.
Developmental Biology Program
Developmental biologist Mary Baylies studies the mechanisms underlying the specification and morphogenesis of muscle during development and disease.
Molecular Pharmacology & Chemistry Program
Epidemiologist Colin Begg focuses on statistical methods for cancer epidemiology, health services research, and clinical trials.
Cancer Biology & Genetics Program
Cancer biologist Robert Benezra studies the molecular mechanisms of tumor growth and progression using mouse Id1 and Id3 knockout models and analysis of the spindle assembly checkpoint.
Molecular Pharmacology & Chemistry Program
Physician-scientist Ronald Blasberg focuses on the development of noninvasive imaging paradigms in living organisms using radionuclide and optical reporter systems.
Memorial Hospital Research Laboratories
Clinician-scientist Michelle Bradbury develops translational, tumor-targeting, PET-optical silica nanoparticle probes for diagnostics, drug delivery, and sensing.
Human Oncology & Pathogenesis Program
Physician-scientist Cameron Brennan focuses on genomic analysis of human and mouse gliomas and medulloblastomas.
Memorial Hospital Research Laboratories
Physician-scientist Renier Brentjens develops novel immunotherapies for leukemias and lymphomas.
Memorial Hospital Research Laboratories
Physician-scientist Jacqueline Bromberg focues on aberrantly activated Stat3 and the mechanisms of Stat3-mediated transformation.
Memorial Hospital Research Laboratories
Physician-scientist Jorge Carrasquillo focuses on the development of targeted radioimmunotherapy drugs.
Molecular Pharmacology & Chemistry Program
Molecular biologist Luca Cartegni investigates the role of alternative splicing events in the development or maintenance of cancer.
Memorial Hospital Research Laboratories
Physician-scientist Brett Carver focuses on the identification of molecular pathways involved in prostate cancer initiation and progression.
Cell Biology Program
Geneticist Raju Chaganti studies genomic instability in cancer cells and its implications for clinical behavior of tumors and normal cellular developmental pathways.
Human Oncology & Pathogenesis Program
Physician-scientist Timothy Chan focuses on the identification and characterization of tumor suppressors in glioblastoma and breast cancer.
Human Oncology & Pathogenesis Program
Physician-scientist Sarat Chandarlapaty studies the regulation of growth factor signaling networks in cancer.
Immunology Program
Immunologist Jayanta Chaudhuri studies the mechanisms of immunoglobulin gene diversification.
Human Oncology & Pathogenesis Program
Physician-scientist Yu Chen studies the role of transcription factors that are critical for prostate cancer development.
Memorial Hospital Research Laboratories
Physician-scientist Nai-Kong Cheung focuses on engineering of antibodies and immune cells to treat solid tumors in children.
Human Oncology & Pathogenesis Program
Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic transcription factors in GIST and other solid tumors.
Molecular Pharmacology & Chemistry Program
Chemical biologist Gabriela Chiosis studies the pharmacological modulation of molecular chaperones in transformed systems.
Computational Biology Program
Computational chemist John Chodera uses statistical mechanics, molecular modeling, and automated biophysical experiments to help identify new potential therapeutics and investigate mechanisms of drug resistance in cancer.
Molecular Pharmacology & Chemistry Program
Chemical biologist Bayard Clarkson focuses on the development of targeted therapies aimed at cancer stem cells.
Memorial Hospital Research Laboratories
Medical physicist Amita Shukla Dave is developing a program in multimodality imaging for head and neck cancer and developing new imaging criteria for prostate cancer.
Chair, Department of Medical Physics; Enid A. Haupt Chair in Medical Physics
Memorial Hospital Research Laboratories
Medical Physics Department Chair Joseph Deasy focuses on integration and analysis of dose, imaging, and molecular data to predict outcomes and guide personalized treatments.
Memorial Hospital Research Laboratories
Physician-scientist Ronald DeMatteo focuses on strategies to reduce immune subversion in gastrointestinal stromal tumor and liver cancer and on immunobiology in liver cancer.
Memorial Hospital Research Laboratories
Physician-scientist Liang Deng studies poxvirus interface with the immune system and the development of poxviruses as oncolytic and immunotherapy for cancers.
Human Oncology & Pathogenesis Program
Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.
Cell Biology Program
Cell biologist Emily Arias Foley investigates the molecular mechanisms of mitosis.
Memorial Hospital Research Laboratories
Physician-scientist Yuman Fong develops herpes-based oncolytic viral therapies for the treatment of malignancy.
Molecular Pharmacology & Chemistry Program
Zvi Fuks studies mechanisms of radiation-induced damage and the clinical basis of radiation resistance.
Cell Biology Program
Cell biologist Hironori Funabiki focuses on regulation of the structure and configuration of chromosomes during the cell division cycle.
Cell Biology Program
Cell biologist Filippo Giancotti investigates signaling by cell adhesion receptors, neoplastic transformation, and metastatic dissemination.
Molecular Pharmacology & Chemistry Program
Synthesis of complex glycoconjugate immunostimulants and anti-cancer, anti-viral natural products.
Immunology Program
Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including regulated intramembrane proteolysis (the Rip1 pathway); double-strand-break repair and associated DNA damage responses; and cell envelope biosynthesis.
Structural Biology Program
Structural biologist Jonathan Goldberg focuses on structural and biochemical characterization of intracellular vesicle transport.
Developmental Biology Program
Developmental biologist Mary Goll investigates the mechanisms of epigenetic regulation and its role in development using zebrafish as a model system.
Molecular Pharmacology & Chemistry Program
Radiologist Jan Grimm develops novel activatable molecular imaging approaches for improved detection and monitoring of prostate and other cancers.
Developmental Biology Program
Developmental biologist Anna-Katerina Hadjantonakis studies cell lineage commitment, patterning and morphogenesis of early mammalian embryos.
Chair, Cell Biology Program, SKI
Cell Biology Program
Cell Biology Program Chair Alan Hall studies Rho and Ras GTPases and the control of cell migration, morphogenesis, and polarity.
Cell Biology Program
Cell biologist Cole Haynes focuses on the molecular mechanisms of mitochondrial function during development, aging, and cancer cell growth.
Molecular Pharmacology & Chemistry Program
Chemist Daniel Heller focuses on biomaterials and nanoscale engineering for molecular sensors and targeted therapeutics.
Immunology Program
Cancer immunologist Alan Houghton studies the immune response to cancer, immune recognition of self and mutated molecules, and development of new immunotherapies.
Molecular Pharmacology & Chemistry Program
Radiologist Hedvig Hricak researches methodologies of molecular imaging of prostate and gynecologic tumors.
Human Oncology & Pathogenesis Program
Physician-scientist James Hsieh focuses on developing novel therapeutics targeting cancer cell proliferation; he also directs Memorial Sloan-Kettering’s translational kidney cancer research program.
Memorial Hospital Research Laboratories
Physician-scientist Katharine Hsu studies the biology of human natural killer cells and how they contribute to disease processes.
Developmental Biology Program
Developmental biologist Danwei Huangfu investigates the fundamental mechanisms that govern cell identity and how they could be exploited therapeutically to manipulate cell fates in regenerative medicine.
Memorial Hospital Research Laboratories
Medical physicist John Humm focuses on noninvasive imaging of the tumor microenvironment using nuclear imaging methods.
Molecular Biology Program
Molecular biologist Jerard Hurwitz focuses on mechanisms of eukaryotic DNA replication and the isolation and characterization of the proteins involved.
Human Oncology & Pathogenesis Program
Physician-scientist Jason Huse focuses on the molecular pathogenesis of brain tumors, particularly high-grade gliomas.
Immunology Program
Immunologist Morgan Huse investigates intracellular signaling dynamics in lymphocytes.
Memorial Hospital Research Laboratories
Medical physicist Andrew Jackson studies the relationship between radiotherapy dose distributions and treatment outcome and the optimization of radiotherapy treatment planning.
Molecular Biology Program
Molecular biologist Prasad Jallepalli studies mechanisms of high-fidelity chromosome segregation in human cells.
Developmental Biology Program
Developmental biologist Maria Jasin focuses on double-strand break repair and genomic integrity in mammalian cells and the relationship to tumor suppression.
Cell Biology Program
Cell biologist Xuejun Jiang studies programmed cell death, molecular mechanisms, and their roles in tumorigenesis.
Cancer Biology & Genetics Program
Cancer biologist Johanna Joyce investigates the signaling pathways between cancer cells and their microenvironment in tumor progression, metastasis, and response to therapy.
Developmental Biology Program
Developmental biologist Alexandra Joyner studies the involvement of Hedgehog signaling and homeobox transcription factors in brain development, adult stem cells, and cancer.
Developmental Biology Program
Developmental biologist Julia Kaltschmidt investigates the mechanisms of synaptic specificity underlying mammalian neuronal circuit formation.
Molecular Biology Program
Molecular biologist Scott Keeney investigates mechanisms of the initiation of meiotic recombination.
Director, Sloan-Kettering Division of the Weill Cornell Graduate School of Medical Sciences; Provost, Gerstner Sloan-Kettering Graduate School
Molecular Biology Program
Molecular biologist Thomas Kelly studies regulatory mechanisms that control DNA replication during the cell cycle of eukaryotic cells.
Molecular Pharmacology & Chemistry Program
Pediatric oncologist and cancer biologist Alex Kentsis leads research in functional proteomics and genomic plasticity of refractory pediatric cancers.
Memorial Hospital Research Laboratories
Biochemist and imaging specialist Kayvan Keshari explores changes in cancer metabolism to develop advanced imaging techniques and cancer targets.
Molecular Pharmacology & Chemistry Program
Cancer biologist Michael Kharas studies RNA regulators of self-renewal in both normal and leukemic hematopoiesis.
Cancer Biology & Genetics Program
Stem cell biologist Kitai Kim studies epigenetic regulation of DNA methylation in stem cells and cancer.
Memorial Hospital Research Laboratories
Physician-scientist Moritz Kircher develops novel molecular imaging approaches with a focus on surface-enhanced Raman spectroscopy and magnetic resonance imaging.
Cancer Biology & Genetics Program
Computational biologist Robert Klein focuses on identifying genes responsible for inherited predisposition to cancer.
Molecular Biology Program
Molecular biologist Andrew Koff investigates the role of cell cycle inhibitors in differentiation and how their loss affects tumorigenesis.
Molecular Pharmacology & Chemistry Program
Physician-scientist Richard Kolesnick studies the role of ceramide signaling in radiation-induced vascular dysfunction and tumor regression.
Memorial Hospital Research Laboratories
Physician-scientist Jason Koutcher studies applications of magnetic resonance spectroscopy and imaging to enhance the therapeutic gain of different antineoplastic modalities.
Developmental Biology Program
Developmental biologist Elizabeth Lacy studies the mechanisms of gastrulation and organogenesis during mouse development.
Human Oncology & Pathogenesis Program
Molecular pathologist Marc Ladanyi studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma.
Developmental Biology Program
Developmental biologist Eric Lai focuses on the control of developmental patterning by Notch signaling and microRNAs.
Molecular Pharmacology & Chemistry Program
Radiologist Steven Larson focuses on molecular imaging in animals and humans using high-resolution diagnostic instruments, such as positron emission tomography, and single photon emission tomography.
Associate Member
Computational Biology Program
Computational biologist Christina Leslie focuses on developing machine learning algorithms for computational and systems biology.
Memorial Hospital Research Laboratories
Physician-scientist Douglas Levine studies the genomic basis for prevention and control of ovarian and uterine carcinomas.
Human Oncology & Pathogenesis Program
Physician-scientist Ross Levine focuses on the investigation of genetic basis of hematopoietic malignancies.
Memorial Hospital Research Laboratories
Radiochemist Jason Lewis develops radiopharmaceuticals for the imaging and therapy of cancer.
Memorial Hospital Research Laboratories
Radiation scientist Gloria Li studies the response of cells to stressors such as heat and radiation.
Immunology Program
Immunologist Ming Li studies the mechanisms of T Cell homeostasis, tolerance, and immunity, and their relevance to autoimmune diseases and cancer.
Molecular Pharmacology & Chemistry Program
Biochemist Yueming Li studies function and regulation of transmembrane proteases and development of novel protease-based cancer therapies.
Structural Biology Program
Structural biologist Christopher Lima studies the structural biology of post-translational protein modification and RNA processing.
Cell Biology Program
Cell biologist Jidong Liu investigates the molecular mechanisms of RNA interference, function, and regulation of mammalian cytoplasmic processing bodies.
Chair, Geoffrey Beene Cancer Research Center
Cancer Biology & Genetics Program
Biologist Scott Lowe investigates tumor-suppressor gene networks that control apoptosis and senescence.
Molecular Pharmacology & Chemistry Program
Chemist Minkui Luo develops chemical tools to elucidate protein-posttranslational modification and designs inhibitors for cancer therapies.
Chief, Computer Service
Memorial Hospital Research Laboratories
Medical physicist Gikas Mageras focuses on radiation treatment planning and verification using CT images to guide radiation treatment and monitor and correct for patient internal and external movement during treatment delivery.
Chair, Molecular Biology Program, SKI; Dean, Gerstner Sloan-Kettering Graduate School
Molecular Biology Program
Molecular Biology Program Chair Kenneth Marians focuses on mechanisms of replication restart and chromosome segregation.
Cell Biology Program
Cell biologist Paul Marks focuses on the study of agents that selectively target histone deacetylases and cause transformed cell growth arrest, terminal differentiation, apoptosis, and/or cell death.
Chair, Cancer Biology & Genetics Program, SKI
Cancer Biology & Genetics Program
Cancer Biology & Genetics Program Chair Joan Massagué studies the control of stem cell growth and phenotype in tumor progression, metastasis, and response to therapy.
Cancer Biology & Genetics Program
Cancer biologist Christine Mayr focuses on gene regulation and definition of the end of an mRNA or a transcription unit.
Memorial Hospital Research Laboratories
Physician-scientist Babak Mehrara studies the regulation of lymphatic regeneration after surgery and development of lymphedema.
Human Oncology & Pathogenesis Program
Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.
Cell Biology Program
Cell biologist Malcolm Moore focuses on the characterization of normal and cancer stem cells and the development of selective therapies.
Cell Biology Program
Cell biologist Philipp Niethammer investigates wound responses in vertebrates on a systems biology level using advanced imaging approaches and genomic techniques.
Structural Biology Program
Structural biologist Dimitar Nikolov focuses on the structural, biophysical, and biochemical characterization of the molecular mechanisms of cell-cell interactions and signal transduction in the nervous system.
Immunology Program
Physician-scientist Richard O'Reilly investigates the genetic disparities and cellular interactions between donor and host that affect allogeneic hematopoietic cell transplantation.
Memorial Hospital Research Laboratories
Cancer geneticist Kenneth Offit focuses on gene characterization; genetic and epidemiologic studies of cancer-predisposing alleles; and the therapeutic, prognostic, and psychosocial translation of these findings.
Cell Biology Program
Cell biologist Michael Overholtzer studies the mechanisms of tumor initiation and progression, cell adhesion, and cell death.
Immunology Program
Physician-scientist Eric Pamer studies T cell and innate inflammatory responses to bacterial and fungal infections.
Memorial Hospital Research Laboratories
Physician-scientst Ying-Xian Pan studies the transcription regulation and function of opioid receptor genes.
Human Oncology & Pathogenesis Program
Physician-scientist Christopher Park focuses on the identification and characterization of molecular pathways that regulate normal and malignant stem cells in the hematopoietic system.
Molecular Pharmacology & Chemistry Program
Pharmacologist Gavril Pasternak studies molecular mechanisms of opioid receptor actions, analgesics, and G-protein-coupled receptors.
Structural Biology Program
Structural biologist Dinshaw Patel studies the structural biology of macromolecular recognition, including RNA catalysis, RNA interference, and bypass of DNA damage.
Chair, Structural Biology Program, SKI
Structural Biology Program
Structural Biology Program Chair Nikola Pavletich studies the structural biology of oncogenes and tumor suppressors.
Structural Biology Program
Structural biologist Alexandros Pertsinidis uses structural molecular and structural cell biology to study novel optical imaging and spectroscopy technologies to understand the function of complex macromolecular machines inside living cells.
Molecular Biology Program
Molecular biologist John Petrini investigates the repair of chromosomal breaks and the activation of the DNA-damage-induced cell-cycle checkpoints.
Memorial Hospital Research Laboratories
Physician-scientist Vladimir Ponomarev focuses on developing reporter genetic systems for specific applications such as sequential in vivo imaging studies in cancer biology, cancer immunotherapy, and radiation sciences.
Molecular Biology Program
Molecular biologist Simon Powell investigates DNA replication and recombination, chromosome dynamics, and human genetics.
Molecular Biology Program
Molecular biologist Mark Ptashne studies mechanisms of gene regulation.
Molecular Biology Program
Molecular biologist Xiaohui Qu conducts high-resolution, single-molecule studies of the molecular mechanisms of ribosome functions and gene expression control.
Memorial Hospital Research Laboratories
Physician-scientist Govind Ragupathi studies tumor vaccinology, including approaches to augmenting the antibody and T cell response to defined cancer antigens.
Memorial Hospital Research Laboratories
Optical engineer Milind Rajadhyaksha studies confocal microscopy for the imaging of cancer, technology development, and translational and clinical studies in skin and head and neck cancers.
Memorial Hospital Research Laboratories
Physician-scientist Shyam Rao studies the role of the tumor microenvironment in tumorigenesis and response to radiation therapy.
Memorial Hospital Research Laboratories
Imaging specialist Thomas Reiner focuses on the development of novel imaging probes for both PET imaging and optical imaging technologies.
Human Oncology & Pathogenesis Program
Physician-scientist Jorge Reis-Filho focuses on the development of a predictive molecular classification for rare types of breast cancer and characterization of intratumor genetic heterogeneity in breast cancers.
Molecular Biology Program
Molecular biologist Dirk Remus investigates mechanisms of DNA replication in eukaryotic cells.
Cell Biology Program
Cell biologist Marilyn Resh investigates the regulation of protein function by fatty acylation, and the development of Hedgehog palmitoylation inhibitors to block pancreatic cancer.
Molecular Pharmacology & Chemistry Program
Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.
Chair, Immunology Program, SKI
Immunology Program
Immunology Program Chair Alexander Rudensky focuses on immunological tolerance and the differentiation and function of T cells.
Cell Biology Program
Cell biologist Timothy Ryan studies the molecular basis of synaptic transmission in the mammalian brain.
Molecular Pharmacology & Chemistry Program
Immunologist Michel Sadelain studies the mechanisms governing transgene expression, stem cell engineering, and genetic strategies to enhance immunity against cancer.
Chair, Computational Biology Program, SKI
Computational Biology Program
Computational Biology Program Chair Chris Sander focuses on analyzing and simulating biological processes at different levels of organization.
Chair, Human Oncology and Pathogenesis Program
Human Oncology & Pathogenesis Program
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
Chair, Molecular Pharmacology & Chemistry Program, SKI
Molecular Pharmacology & Chemistry Program
Molecular Pharmacology and Chemistry Program Chair David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
Memorial Hospital Research Laboratories
Physician-scientist Gary Schwartz focuses on the identification of cell-cycle inhibitors that promote chemotherapy-induced apoptosis and their use in cancer therapy.
Developmental Biology Program
Developmental neurobiologist Songhai Shi investigates the molecular and cellular mechanisms underlying mammalian neuronal development and circuit formation.
Molecular Biology Program
Molecular biologist Stewart Shuman studies mechanisms and structures of the mRNA cap-forming enzymes and the means by which capping is coupled to transcription.
Memorial Hospital Research Laboratories
Physician-scientist Samuel Singer studies the genomic alterations that define new targets for therapy in sarcoma.
Memorial Hospital Research Laboratories
Physician-scientist Bhuvanesh Singh focuses on delineating the role of ubiquitination in cancer pathogenesis.
Human Oncology & Pathogenesis Program
Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.
Memorial Hospital Research Laboratories
Physician-scientist David Spriggs studies the molecular mechanisms of drug resistance in ovarian cancer.
Immunology Program
Immunologist Joseph Sun investigates the natural killer cell response against infection and cancer.
Memorial Hospital Research Laboratories
Physician-scientist Viviane Tabar focuses on in vivo applications of neural derivatives of pluripotent stem cells (such as iPS and ES cells) and on cancer stem cells in human brain tumors.
Molecular Pharmacology & Chemistry Program
Chemist Derek Tan studies diversity-oriented synthesis and rational drug design for chemical biology and drug discovery.
Memorial Hospital Research Laboratories
Physician-scientist Laura Tang studies the molecular pathogenesis of cell transformation in neuroendocrine neoplasms of the gastrointestinal tract and pancreas and adenocarcinomas of the stomach and gastrointestinal junction.
Molecular Biology Program
Molecular biologist Paul Tempst focuses on the development of proteomic technologies and approaches for studying the eukaryotic transcriptional machineries and for cancer biomarker discovery.
Memorial Hospital Research Laboratories
Medical physicist Sunitha Thakur focuses on MR biomarkers for early detection and monitoring response to treatment.
President and CEO, Memorial Sloan-Kettering Cancer Center
Cancer Biology & Genetics Program
Memorial Sloan-Kettering President Craig Thompson studies molecular signaling pathways that regulate nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
Cell Biology Program
Cell biologist Meng-Fu Bryan Tsou studies cell cycle control of centrosome duplication and degeneration, as well as cilia assembly and disassembly.
Immunology Program
Physician-scientist Marcel R. M. van den Brink studies the immunology of bone marrow transplantation.
Cancer Biology & Genetics Program
Cancer biologist Andrea Ventura studies non-coding RNAs in cancer and development
Memorial Hospital Research Laboratories
Physician-scientist Wolfgang Weber specializes in imaging and therapy, with a focus on the translation of novel drugs, imaging agents, and methodologies from bench to bedside.
Computational Biology Program
Computational biologist Harel Weinstein investigates the structural, dynamic, and integrative determinants of molecular and cellular mechanisms underlying physiological function and pharmacological activity.
Memorial Hospital Research Laboratories
Physician-scientist Martin Weiser investigates the mechanisms underlying tumor spread and metastasis and how these mechanisms could be targeted.
Cancer Biology & Genetics Program
Cancer biologist Hans-Guido Wendel focuses on modeling the genetics of tumor initiation, progression, and treatment response in vivo.
Cancer Biology & Genetics Program
Cancer biologist Richard Mark White investigates the evolution of metastases in zebrafish.
Molecular Biology Program
Molecular biologist Iestyn Whitehouse investigates chromatin structure and the function of ATP-dependent chromatin remodelling enzymes.
Immunology Program
Physician-scientist Jedd Wolchok investigates novel approaches for cancer immunotherapy and mechanisms of tumor cell–immune cell interactions.
Memorial Hospital Research Laboratories
Physician-scientist Richard Wong studies the mechanisms of cancer cell chemotaxis in perineural invasion.
Computational Biology Program
Computational biologist Joao Xavier studies computer models and quantitative experiments of biofilm and cancer growth.
Memorial Hospital Research Laboratories
Physician-scientist Sam Yoon studies the role of tumor microenvironment in the progression and radiation response of sarcomas and gastric cancer.
Memorial Hospital Research Laboratories
Physician-scientist James Young studies innate and adaptive immunity against tumors and viruses stimulated by human dendritic cells.
Developmental Biology Program
Developmental biologist Jennifer Zallen focuses on the generation of tissue structure through the collective action of cell populations.
Molecular Biology Program
Molecular biologist Xiaolan Zhao studies chromosomal organization, telomere metabolism, DNA repair, and dynamic protein modification in stable genome maintenance.
